Antimicrobial Resistance News and Research

RSS

Evolution of Antibiotic Tolerance Promotes Resistance to Combination Regimens

A new study suggests that the evolution of antibiotic tolerance requires further investigation if newly designed antibiotic treatments are going to be able to prevent drug-resistant infections.

10 Jan 2020

Scientists discover how bacterial evolution of antibiotic arsenals is providing new drug blueprints

Scientists from Trinity College Dublin have discovered that two very different species of bacteria have evolved distinct, powerful antibiotic arsenals for use in the war against their bacterial neighbors.

9 Jan 2020

A new deep learning approach to predict disease-associated mutations

During the past years, artificial intelligence (AI) -- the capability of a machine to mimic human behavior -- has become a key player in high-techs like drug development projects.

28 Dec 2019

Pet store puppies appear to be carrying a dangerous bacterium, warns CDC

The CDC has warned that pet store puppies may be making people sick by transmitting a dangerous antibiotic-resistant bacterium.

19 Dec 2019

New gene technology shows 100-fold efficiency in targeting antibiotic-resistant bacteria

Taking advantage of powerful advances in CRISPR gene editing, scientists at the University of California San Diego have set their sights on one of society's most formidable threats to human health.

16 Dec 2019

Americans are taking fish antibiotics to save money

Alarming results from a new study show that people in the United States buying fish antibiotics online and consuming them because they’re more affordable than to go visit a doctor. The study sheds light on the high costs of health care in the country and how citizens are struggling to afford basic services.

12 Dec 2019

New antimicrobial polymer can kill bacteria resistant to common antibiotics

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, and Nanyang Technological University have designed an antimicrobial polymer that can kill bacteria resistant to commonly used antibiotics, including the superbug Methicillin-resistant Staphylococcus aureus (MRSA).

12 Dec 2019

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

8 Dec 2019

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

6 Dec 2019

Research yields potent antimicrobial that works against staph infection

Research led by scientists from McMaster University has yielded a potent antimicrobial that works against the toughest infectious disease strains. The find could be the beginning of developing new therapeutics to combat drug-resistant infections.

25 Nov 2019

Potent antimicrobial could combat antibiotic-resistant MRSA infections

Scientists have discovered a strong antimicrobial that is effective against some of the strongest infectious diseases.

25 Nov 2019

Researchers investigate a hospital outbreak in real time using high-resolution technique

On the European Antibiotic Awareness Day, researchers announce the results of a pilot study completed in record time. The initiative opens new perspectives for the control of bacterial infections in Portuguese hospitals.

21 Nov 2019

Antibiotics face an existential crisis

Antibiotics are facing an existential crisis less than a century after their introduction. The bacteria-fighting drugs are becoming less effective as a result of their overuse in both humans and animals.

18 Nov 2019

Increase in drug-resistant infections could put 10 million lives in the UK at risk

Antimicrobial resistance should be taken more seriously, yet more than 99% of the population are not fully aware of its impact. This is despite the outgoing UK Chief Medical Officer saying earlier this year that Superbugs “could kill us before climate change does”.

18 Nov 2019

First Ebola vaccine prequalified by WHO for use in high-risk countries

The world's first Ebola vaccine has been prequalified by the World Health Organization (WHO).

14 Nov 2019

Report highlights health and economic impact of antimicrobial resistance in Canada

In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.

12 Nov 2019

New bacteria-killing toxin shows promise to impact superbug infectious diseases

An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.

6 Nov 2019

Differences between colloidal silver and ionic silver solutions

There are many differences between colloidal silver and ionic silver solutions. Philip Marshall discusses what makes these silver solutions unique.

From Pure Colloids 6 Nov 2019

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms on the fully-automated BD MAX System.

From BD (Becton, Dickinson and Company) 30 Oct 2019